May Link To Cancer,
Paralysis and Death
“Polyomavirus simian virus 40 (SV40) is a known oncogenic DNA virus which induces primary
brain and bone cancers, malignant mesothelioma, and lymphomas in laboratory animals.” New studies have
revealed that SV40 can cause not only infections but also many serious diseases in humans, including
According to a meta-analysis conducting
on molecular data and clinical pathological of 1,793 cancer patients, SV40 is associated with a considerable
risk of many cancers such as brain cancer, bone cancer, malignant mesothelioma, and non-Hodgkin lymphoma. In
addition, Experimental data shows significant evidence that SV40 can lead to the occurrence of these cancers in
human. “Therefore, the main types of tumors induced by SV40 in laboratory animals are the same as human
malignancies containing markers for SV40”, say the scientists.
However, The Center for Disease Control
(CDC) admitted that “98 million Americans have been infected for eight years with polio vaccines containing the
carcinogenic virus SV40.” The public was kept in ignorance for decades about the contamination of the polio
vaccines with the Simian Virus 40 (SV40), and its enormous implications in the rising global cancer epidemic,
although the scientific community was well aware of these facts since 1960.
But thanks to prosecution,
investigation reports in the 1990s, and a Congressional hearing in 2003, the public has been informed of the
extent of contamination and its possible link with a large number of fatal forms of cancer that are still
destroying life today. Yet the great majority of people in the public are not aware of the facts, and still
promoting the “so-called safety and beneficial effects” of those vaccines.
In the wake of these admissions and
inquiries, the CDC issued a fact sheet on its website which relates to the links between many types of cancer,
Simian Virus 40 (SV40), and the vaccines against polio: inactivated poliovirus vaccine (IPV) and oral poliovirus
vaccine (OPV). “The document confirmed the presence of SV40 in about 10 to 30 million doses of polio vaccines.
But it also challenged the scientific claims regarding the presence of the virus in cancerous tumors and its
possible role in causing cancers.
Even worse, in the late 1990s
scientists found that there was a secondary form of this SV40 in polio vaccines manufactured after 1963 but
which was not detected by the tests previously done. This could mean that the impact of this virus on the
public, though little known, could have been much more extensive than we can possibly imagine.
But from June 2013, the CDC page was
apparently removed from their website. It is no longer available except in a version (cached) recovery in a
video. It is believed the removal was done so that manufacturers of these vaccines are not responsible for this
cruelty. However, pharmaceutical companies continue to produce these vaccines, and they are administered daily
to the Americans and people all over the world.
The number of deaths caused by polio
vaccine over several decades is not known. Nobody knows exactly how many people have killed by cancers caused by
these polio vaccines supposed to "save lives", considering people in different part of the work receive polio
vaccine as recommended by their physician.
The number of these people is undoubtedly likely to be several thousand times, far
greater than the number of lives that would have allegedly been saved from “polio" without
Emergent Human Pathogen Simian Virus 40
and Its Role in Cancer: Regis A. Vilchez and
Janet S. Butel - PMCID:
Polio eradication: a complex end
BMJ 2012 ; 344 doi :
(Published 02 April 2012)
Cite this as: BMJ 2012;344:e2398
Shah, K; Nathanson, N (January 1976). “Human exposure to SV40: Review and
Journal of Epidemiology 103 (1): 1–12.
Sweet, B. H.; Hilleman, M. R. (November 1960). “The vacuolating virus, S.V.
40″. Proceedings of the
Society for Experimental Biology and Medicine. Society for Experimental Biology and
Medicine 105 (2): 420–427.
Eddy, B. E.; Borman, G. S.; Grubbs, G. E.; Young, R. D. (May 1962). “Identification of the
oncogenic substance in rhesus monkey kidney cell culture as simian virus
Fiers, W; Contreras, R; Haegemann, G; Rogiers, R; Van De Voorde, A; Van Heuverswyn, H; Van
Herreweghe, J; Volckaert, G; Ysebaert, M (May 1978). “Complete nucleotide sequence of SV40
DNA”. Nature 273 (5658): 113–20.
Yamamoto, Hiroshi; Shimojo, H (August 1971). “Multiplicity reactivation of human adenovirus
type 12 and simian virus 40 irradiated by ultraviolet light”. Virology 45 (2): 529–31.
Hall, J. D. (1982). “Repair of psoralen-induced crosslinks in cells multiply infected with
SV40″. Molecular &
General Genetics 188 (1): 135–8.
Michod, Richard E.; Bernstein, Harris; Nedelcu, Aurora M. (2008). “Adaptive value of sex in
microbial pathogens”. Infection, Genetics and
Evolution 8 (3): 267–85.
Eibl, R. H.; Kleihues, P; Jat, P. S.; Wiestler, O. D. (1994). “A model for primitive neuroectodermal tumors in transgenic
neural transplants harboring the SV40 large T antigen”. The American journal of
pathology 144 (3): 556–64.
Poulin, D. L.; Decaprio, J. A. (2006). “Is There a Role for SV40 in Human
Cancer?”. Journal of
Clinical Oncology 24 (26): 4356–65.
Lowe, D. B.; Shearer, M. H.; Jumper, C. A.; Kennedy, R. C. (2007). “SV40 association with
human malignancies and mechanisms of tumor immunity by large tumor antigen”. Cellular and Molecular Life
Sciences 64 (7–8): 803–14.
Shah, K. V. (2007). “SV40 and human cancer: A review of recent
Journal of Cancer. Journal International Du Cancer 120 (2): 215–23.
Moens, U; Van Ghelue, M; Johannessen, M (2007). “Oncogenic potentials of the human
polyomavirus regulatory proteins”. Cellular and molecular life sciences :
CMLS 64 (13): 1656–78.
Barbanti-Brodano, G; Sabbioni, S; Martini, F; Negrini, M; Corallini, A; Tognon, M (2004).
“Simian virus 40 infection in humans and association with human diseases: results and
hypotheses”. Virology 318 (1): 1–9.
“Studies Find No Evidence That SV40 is Related to Human
Cancer”. National Cancer Institute, National Institutes of Health. 23 August 2004.
Engels, E. A.; Chen, J; Hartge, P; Cerhan, J. R.; Davis, S; Severson, R. K.; Cozen, W;
Viscidi, R. P. (2005). “Antibody Responses to Simian Virus 40 T Antigen: A Case-Control Study of Non-Hodgkin
Epidemiology Biomarkers & Prevention 14 (2): 521–4.
Engels, Eric A.; Katki, Hormuzd A.; Nielsen, Nete M.; Winther, Jeanette F.; Hjalgrim, Henrik;
Gjerris, Flemming; Rosenberg, Philip S.; Frisch, Morten (2003). “Cancer Incidence in Denmark Following Exposure
to Poliovirus Vaccine Contaminated with Simian Virus 40″. JNCI Journal of the National Cancer
Institute 95 (7): 532–9.
Stratton, Kathleen; Almario, Donna A.; McCormick, Marie C., eds.
(2002). “Immunization Safety Review: SV40 Contamination of Polio
Vaccine and Cancer”. Immunization Safety Review: SV40 Contamination of
Polio Vaccine and Cancer. The National Academy of Sciences.
Namiki, K; Goodison, S; Porvasnik, S; Allan, R. W.; Iczkowski, K. A.; Urbanek, C; Reyes, L;
Sakamoto, N; Rosser, C. J. (1 September 2009). “Persistent exposure to Mycoplasma induces malignant
transformation of human prostate cells”. PLoS ONE 4 (9): e6872.
Kroczynska, B; Cutrone, R; Bocchetta, M; Yang, H; Elmishad, A. G.; Vacek, P; Ramos-Nino, M;
Mossman, B. T.; Pass, H. I.; Carbone, M (2006). “Crocidolite asbestos and SV40 are cocarcinogens in human
mesothelial cells and in causing mesothelioma in hamsters”. Proceedings of the National Academy of Sciences
of the United States of America 103 (38): 14128–33.
Pershouse, M. A.; Heivly, S; Girtsman, T (2006). “The role of SV40 in malignant mesothelioma
and other human malignancies”. Inhalation
toxicology 18 (12): 995–1000.
Ferber, Dan (2002). “Virology. Monkey virus link to cancer grows
stronger”. Science 296 (5570): 1012–1015. Archived from the original on May 10,
Baggott, Mary Tim, ed. (2007). Nature, the Physician, and the Family: Selected
Writings of Herbert Ratner, M.D. AuthorHouse.
pp. xv–xvii. ISBN 978-1-4184-7510-9.
Bookchin, Debbie; Schumacher, Jim (2004). The Virus and the Vaccine. St. Martin’s Press. pp. 226–28.
Rizzo, Paola; Di Resta, Ilaria; Powers, Amy; Ratner, Herbert; Carbone, Michele
(1999). “Unique Strains of SV40 in Commercial Poliovaccines from 1955
Not Readily Identifiable with Current Testing for SV40 Infection”. Cancer
Research 59 (24): 6103–8.
Martini, F; Corallini, A; Balatti, V; Sabbioni, S; Pancaldi, C; Tognon, M (9 July
2007). “Simian virus 40 in humans”. Infectious agents and
Bookchin, Debbie (7 July 2004). “Vaccine scandal revives cancer
fear”. New Scientist.
NIH/National Cancer Institute (2004-08-25). “Studies Find No Evidence That Simian Virus 40 Is Related To
Human Cancer”. Science Daily.
Hilleman MR (1998). “Discovery of simian virus 40 (SV40) and its relationship to
poliomyelitis virus vaccines.”. Dev Biol
Carroll-Pankhurst, C; Engels, EA; Strickler, HD; Goedert, JJ; Wagner, J; Mortimer EA Jr. (Nov
2001). “Thirty-five year mortality following receipt of SV40-
contaminated polio vaccine during the neonatal period.”. Br J Cancer 85 (9): 1295–7.